LYNETTE JUBAY: Open Payments
NPI 1316045479 · LARGO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,465 in 158 payments from 26 companies in 2025. Trend: 2023 $3,301 · 2024 $2,829 · 2025 $3,465
Food & beverage: $3,390Consulting: $41Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 22 | $547 |
| CSL Behring | 24 | $538 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $297 |
| Regeneron Healthcare Solutions, Inc. | 10 | $261 |
| Novartis Pharmaceuticals Corporation | 10 | $242 |
| GlaxoSmithKline, LLC. | 15 | $227 |
| Amgen Inc. | 9 | $204 |
| BioCryst US Sales Co., LLC | 7 | $203 |
| Genentech USA, Inc. | 12 | $196 |
| GENZYME CORPORATION | 3 | $103 |
Products named: DUPIXENT, FASENRA, Hizentra, Xolair, TEZSPIRE, ORLADEYO, NUCALA, CUVITRU.
Industry payments across FL — which companies pay providers there.
